OMER vs ZYME

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 31, 2026

OMER

47.0
AI Score
VS
OMER Wins

ZYME

33.4
AI Score

Investment Advisor Scores

OMER

47score
Recommendation
HOLD

ZYME

33score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric OMER ZYME Winner
Forward P/E 74.6269 21.8818 ZYME
PEG Ratio 0.8053 0 Tie
Revenue Growth 14.9% -90.6% OMER
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 47.0/100 33.4/100 OMER
Profit Margin 324.9% 0.0% OMER
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY OMER

Relative Price Performance (Last 90 Days)

OMER 1M: -3.9% · 3M: +4.6% ZYME 1M: +16.0% · 3M: +12.8%

Current Technical Phase

OMER

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 53

RSI (14): 52.7 · Price: $18.15

ZYME

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.1% over 20 days), RSI 53

RSI (14): 52.9 · Price: $29.07

Fundamentals Snapshot

Metric OMER ZYME
Market Cap — —
Forward P/E 14.8 23.9
Trailing P/E 14.2 59.4
Revenue (TTM) — —
Revenue Growth 0.1% 8.3%
Gross Margin 0.4% 0.5%
Operating Margin 0.0% 0.7%
EPS 1.22 0.53
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, OMER is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.